Bridgebio Pharma Inc (BBIO)
$74.95 +5.97% Close Oct 30, 2026 Live
Bridgebio Pharma stock today
Bridgebio Pharma closed at $74.95 on October 30, 2026, up 5.97% on the day. Over the past year it returned +18.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $14.7 billion.
$60.00$70.00$80.00$90.00
NovJan 2026MarMayJulSep
| Period | BBIO | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.9% | -0.9% |
| 3 months | -8.8% | +2.1% |
| Year to date | -2.0% | +11.7% |
| 1 year | +18.3% | +12.4% |
| 3 years | +193.8% | +88.5% |
| 5 years | +51.8% | +76.0% |
Key statistics
- Market value
- $14.7B
- Price / sales
- 15.5
- 52-week range
- $61.37 to $90.17
About Bridgebio Pharma
BridgeBio Pharma develops medicines for severe genetic diseases.
Sector: Health Care
More on Bridgebio Pharma
- Financials: revenue, earnings and segmentsRevenue +126% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $1,518 today
No forecast, no recommendation. This page describes Bridgebio Pharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.